New gel may improve tear duct surgery outcomes
NCT ID NCT07504250
First seen Apr 01, 2026 · Last updated Jun 23, 2026 · Updated 15 times
Summary
This study tests whether using hyaluronic acid gel during tear duct surgery works as well as the standard drug mitomycin-C. About 36 adults with chronic blocked tear ducts will be randomly assigned to receive one of the two treatments during surgery. The goal is to see which leads to better tear drainage, fewer complications, and faster healing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DACRYOCYSTITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
hyaluronic acid (gel) and mitomycin-C (drug)
What this could lead to
If hyaluronic acid works as well as mitomycin-C, it could offer a safer option during tear duct surgery with fewer side effects.
What could go wrong
This is a small, early-phase trial with only 36 participants, so results may not apply to everyone. The study hasn't started yet, and the benefits over standard care are uncertain.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.